Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Pulmonary hypertension As per available reports about 22 relevant Journals, 40 Conferences, 12 National symposiums are presently dedicated exclusively to pediatric hypertension and about 2070 articles are being published on Pediatric hypertension.
Pulmonary hypertension (or PHT) is high blood pressure that occurs in the arteries in the lungs. It is a different measurement altogether from systemic blood pressure. It reflects the pressure the heart must exert to pump blood from the heart through the arteries of the lungs. Symptoms of PH includes:
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and importance:
The prevalence of hypertension in children and adolescents in the United States has been reported at 1% to 5%. Primary hypertension in children and adolescents is associated with several risk factors, the strongest of which is elevated body mass index. The prevalence of hypertension in children and adolescents has increased over the past several decades, which is probably attributable to the increase in the prevalence of childhood overweight and obesity. The prevalence of hypertension among obese children in the United States is estimated at 11%.
One rationale for screening for hypertension in children and adolescents is that early identification of primary hypertension could lead to interventions to reduce blood pressure during childhood and adolescence, resulting in a reduced risk for cardiovascular events and death in adulthood.
Pulmonary hypertension will be the best platform for all the specialists and super specialists, renowned Scientists, research scholars, students who are working in this field across the globe under a single roof to exchange their knowledge related to pulmonary hypertension. This international event is an effort to find an alternative for invasive imaging technique against diseases like Asbestosis disease , Lung cancer, Pandemic Flu, Pulmonary Embolism and Respiratory Syncytial Virus etc.
Market Analysis:
According to a new market report published by Transparency Market Research “Pulmonary Arterial Hypertension (PAH) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” the global PAH market was valued at USD 4.04 billion in 2013 and is expected to grow at a CAGR of 2.3% from 2014 to 2020, to reach an estimated value of USD 5.19 billion in 2020.
Pulmonary hypertension is a clinical syndrome where the blood flow that leaves the right side of the heart faces an increased resistance (pressure). Normally blood flows from the right ventricle into the pulmonary arteries and then flows into smaller and smaller blood vessels until it reaches the capillaries (thin walled blood vessels near the small air chambers of the lungs or alveoli). There gas exchange occurs where oxygen is picked up and carbon dioxide is released. The blood vessels have muscles in their walls that can regulate their diameter and thereby allow more or less blood flow to enter the capillaries. In pulmonary hypertension, the blood vessels of the lungs have an increased amount of muscle in the walls. This causes a higher resistance in the lungs. The right ventricle then has to work harder to pump blood out to the lungs. The right ventricle will enlarge and thicken in response to this extra work. With time, the extra work placed on the right side of the heart can cause it to fail. True pulmonary arteriolar hypertension as a result of some, but not all, forms of congenital heart disease, connective tissue disease or sickle cell disease .
Problems that can lead include: patent Ductus Arteriosus (PDA), ventricular septal defects (VSDs) and atrial septal defects (ASDs). These defects can cause damage to the blood vessels by allowing too much blood to flow through your child's lungs (the condition is also called Eisenmenger syndrome). Transposition of the greatarteries is also associated with PH in about 5 % of children with PH. PH sometimes has a genetic cause and can be seen in family members. Some of these genetic causes can be diagnosed by specialized genetic testing.
International symposium and workshops
1. 2nd Workshop of Pulmonary Hypertension, Thessaloniki
2. Pulmonary Hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases
3. Pulmonary Hypertension Professional Network Symposium
4. The 9th PVRI AGM and 8th Scientific Workshops and Debates, Guangzhou, China, January 15-18th 2015
5. The PVRI Get-Together, San Diego, USA
6. Pulmonary Hypertension Fellow Education Day and 10th Pulmonary Hypertension Symposium
List of Best International Conferences:
1. 2nd Respiratory and Pulmonary Medicine Conference May 9-10, 2016, Chicago, USA
2. 3rd Chronic Obstructive Pulmonary Disease conference July 11-12, 2016 Brisbane, Australia
3.6th Clinical Cardiology Conference November 30-December 02, 2015 San Antonio, USA
4. 7th Cardiothoracic Conference March 29-30, 2016 Atlanta, USA
5. 8th Cardiologists Conference July 18-20, 2016 Berlin, Germany
6. Cardiac Nursing Conference May 5-7, 2016 Chicago, USA
7. 2nd Pediatric Cardiology Conference September 22-24, 2016, Las Vegas, USA
8. Transplantation Conference March 28-29, 2016 Atlanta, USA
9. 4th Healthcare Conference July 18-20, 2016 Brisbane, Australia
10. Healthcare Conference November 09-11, 2015 Dubai, UAE
11. 8th Healthcare Conference October 13-15, 2016 Dubai, UAE
12. 6th Healthcare and Fitness Conference August 22-24, 2016 Philadelphia, USA
13. Healthcare Conference October 05-07, 2015 New Delhi, India
14. Hypertension Conference, Aug 4-6, 2016, Toronto, Canada
15. 10th Interventional Cardiology Conference, Sept 12-14, 2016, Berlin, Germany
16. Cardiovascular Imaging Conference, Nov 7-9, 2016, Istanbul, Turkey
17. Angiology Conference Dec 8-10, 2016,San Antonio, USA
18. Internal Medicine Conference, November 03-05, 2016 Baltimore, Maryland, USA
19. Anesthesia and Intensive Care conference September 12-14, 2016 Phoenix, Arizona, USA
20. 4th Surgery conference October 05-07, 2015 Crowne Plaza, Dubai, UAE
21. COPD 2015 October 19, 2015 - October 20, 2015 London , UK
22. London Thoracic Ultrasound Course 2015october 21, 2015 - October 21, 2015 london , London , UK
23. Chest 2015 October 24, 2015 - October 28, 2015montréal , Canada
24. Hellenic Thoracic Society 24th National Congress 2015november 12, 2015 - November 15, 2015 Greece
25. 20th Congress of The Asia Pacific Society of Respirology 2015december 3, 2015 - December 6, 2015, kuala Lumpur , Malaysia
26. February 2016 International Conference: Clinical Update Sleep 2016february 26, 2016 - February 26, 2016london , UK
Relevant Society and Associations
1. ABRAHP [Associacao Brasileira de Hipertensao Pulmonar] – Brazil
2. Pulmonary Hypertension Association of Canada (PHA Canada)
3. Calgary Pulmonary Hypertension Support Group
4. Edmonton Pulmonary Hypertension Support Group
5. Pulmonary Hypertension Association, UK
6. Pulmonary Hypertension Association of Canada
7. Pulmonary Hypertension Society of Australia and New Zealand
8. American Thoracic Society
9. Saudi Association for Pulmonary Hypertension
10. The Scleroderma Society
11. European Respiratory Society
12. Swiss Society of Pulmonary Hypertension
13. Pulmonary Hypertension Society of Ontario
14. The International CTEPH Association (ICA)
15. British Columbia Pulmonary Hypertension Society (BCPHS)
16. University of British Columbia PH Society (UBCPHS)
17. The Manitoba Pulmonary Hypertension Support Group
18. New Brunswick PH Society (NBPHS)
19. The Pulmonary Hypertension Society of Ontario
20. Fundación Colombiana de Hipertension Pulmonar
21. Sdruzeni Pacientu s Plicni Hypertenszi
22. HTAP (HyperTension Artérielle Pulmonaire) – France
23. Pulmonale hypertonie e.v. – Germany
24. Pulmonary Hypertension Association – Ireland
25. AMIP (Associazione Malati Ipertensione Polmonare) – Rome
26. La Sociedad Latina de Hipertensión Pulmonar
27. Asociación Peruana de Hipertensión Pulmonar
28. Pulmonary Hypertension Association Romania
Companies
1. Fairview Specialty Pharmacy
2. Gilead Sciences
3. Pulmokine
4. Accredo Therapeutics
5. Actelion Pharmaceuticals US, Inc.
6. Bayer HealthCare
7. Cane Medical Technology
8. CVS Caremark
9. Fairview Specialty Pharmacy
10. Gilead Sciences
11. GlaxoSmithKline
12. Lilly
13. Lung LLC
14. Medtronic
15. Pfizer
16. Philips Respironics
17. United Therapeutics
18. Smiths Medical
19. Teva Pharmaceuticals
20. Walgreens Specialty Pharmacy
21. Bayer
This page will be updated regularly.
This page was last updated on November 24, 2024
